… , is associated with an increased risk of esophageal adenocarcinoma. We assessed whether
endoscopic radiofrequency ablation could eradicate dysplastic Barrett's esophagus and …

… evaluated endoscopic radiofrequency ablation (RFA) for patients with nondysplastic Barrett’s
esophagus (NDBE… Eradication of Barrett esophagus with early neoplasia by radiofrequency …

… After radiofrequency ablation (RFA), patients may experience recurrence of Barrett’s esophagus
(BE) after complete eradication of intestinal metaplasia (CEIM). Rates and predictors of …

… In patients with Barrett's esophagus (BE), radiofrequency ablation (RFA) safely and effectively
eradicates dysplasia and intestinal metaplasia. We aimed to determine the efficacy and …

… Radiofrequency ablation (RFA) with or without endoscopic mucosal resection (EMR) is
routinely used for treatment of Barrett’s esophagus with dysplasia. Despite the relative safety of …

… Radiofrequency ablation (RFA) can eradicate dysplasia and intestinal metaplasia in
patients with dysplastic Barrett's esophagus (BE), and reduce rates of esophageal … , disease …

… Our analysis found that radiofrequency ablation of Barrett's HGD appears appropriate
because it is more effective and less costly than continued endoscopic surveillance with surgery …

… Radiofrequency ablation (RFA) is safe and effective for eradicating intestinal metaplasia and
neoplasia in patients with Barrett's esophagus. We sought to assess the safety and efficacy …

… Given the shortcomings of the competing strategies, mucosal ablation is appealing as a …
endoscopic ablative strategies that have been studied in recent years, radiofrequency ablation (…

… radiofrequency ablation on the risk of neoplastic progression in patients with Barrett esophagus
… 25% to 40% of patients with Barrett esophagus are diagnosed with low-grade dysplasia …